Financial Data and Key Metrics Changes - GAAP revenue increased to $7.739 million in 2024 from $7.355 million in 2023, driven by higher demand for mobile systems and IHP corporate service revenue [51] - Non-GAAP revenue was approximately $8 million, reflecting nearly a 6% increase over 2023 [52] - GAAP net loss was $4.477 million or $0.22 per share compared to a net loss of $3.403 million or $0.17 per share in the prior year [57] Business Line Data and Key Metrics Changes - Mobile equipment sales totaled approximately $3.8 million in 2024, reflecting a 23% growth compared to 2023 [54] - Service revenue generated around $2 million, a 23% increase from the previous year [54] - BIT solution sales reached approximately $900,000, marking a 9% growth [54] Market Data and Key Metrics Changes - The IHP corporate service division secured contracts extending through 2026, with a 42% increase in Q1 2025 compared to the same period last year [29] - Distribution arrangements resulted in 13 partners, leading to approximately $930,000 in sales for 2024 [27] Company Strategy and Development Direction - The company aims to expand the SteriMIST IHP brand globally and has established valuable partnerships in key markets [16] - Focus on enhancing sales infrastructure by establishing new distribution channels and recruiting independent representatives [59] - Plans to nurture the pipeline of CES hybrid and SIS sales to positively impact revenue in 2025 and beyond [60] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about future growth, highlighting early successes in 2025 and a healthy pipeline [15][16] - The company is focused on returning to sustainable positive cash flow as soon as possible [50] - Management acknowledged challenges in the global food market but emphasized ongoing collaborations to address these issues [30] Other Important Information - The company has reduced R&D expenses by 41%, advertising and sales commissions by 17%, and consulting expenses by 20% in 2024 [48] - The company is actively pursuing new EPA labels to support growth within the cannabis and food safety industries [69] Q&A Session Summary Question: Revenue guidance for the year and margin information - Management indicated that margins should remain around current levels and expects additional wins to follow throughout the year [85][89] Question: Impact of tariffs on the company - Management does not anticipate significant ramifications from the tariff situation at this time [100] Question: Adequacy of cash levels to address opportunities - Management is looking to raise funds and believes current cash levels, along with accounts receivable, will be sufficient [102] Question: Status of FDA ruling for 1% solution for food products - Management stated it is hard to predict due to changes within regulatory agencies [110] Question: Modifications to SteriPak - Management confirmed that they are considering upgrades to surface units but are currently marketing the existing SteriPak [112]

Technology and Innovation - SteraMist utilizes a patented Binary Ionization Technology (BIT) to deliver a 7.8% hydrogen peroxide-based fog, achieving a 6-log (99.9999%) kill rate of pathogens[16][17][18]. - The technology has been registered with the EPA since June 2015 and is the first EPA Registered Solution + Equipment combination for hospital-healthcare disinfection[26][27]. - The company has achieved a 99.9999% kill rate on all challenged pathogens with its SteraMist iHP technology, surpassing many competitors that offer only 99.9% to 99.99% efficacy[71]. - The SteraMist Integrated System (SIS) lineup provides versatile options for integrated enclosure decontamination, with SIS-SA stocked in inventory and SIS-Pharm made-to-order[98]. - The SteraMist Hybrid system integrates CES's stainless-steel applicators with the ENV generator, designed for precise fogging control and compliance with industry standards[96]. - The SteraMist equipment is designed to be user-friendly, requiring no preconditioning of spaces before treatment, which streamlines the disinfection process[76]. - The SteraMist Transport unit can treat a variety of vehicle sizes with an application time of only 20 minutes per 1,000 cubic feet, currently in a soft launch phase[86]. - The NV+ solution, designed for smaller areas, features a 36-minute injection time for spaces up to 1,800 cubic feet and is set to debut in April 2024[87]. Market Opportunities and Growth - The life sciences sector is experiencing growth due to global demographic trends and regulatory requirements, with increasing demand for automated decontamination solutions[31][42]. - The global pharmaceutical market is projected to grow steadily, with emerging markets driving demand for consistent and fast decontamination solutions[42][43]. - The food safety sector presents significant growth opportunities, with TOMI's technology demonstrating effectiveness in sanitizing the food supply[50][51]. - Compliance with food safety regulations is critical for businesses to protect public health and maintain consumer trust, with strict sanitation standards enforced by regulatory agencies[52]. - TOMI aims to penetrate the healthcare market by forming strategic partnerships and promoting the integration of SteraMist as a solution to manual cleaning practices[48]. - The company is expanding its presence in the food safety market, engaging with various industries including coffee, desserts, and agribusinesses to integrate iHP SteraMist into their sanitization protocols[214]. Financial Performance - The company generated a net loss of approximately $4.5 million and $3.4 million for the years ended December 31, 2024 and 2023, respectively, with an accumulated deficit of $54.3 million as of December 31, 2024[124]. - The company reported a net loss of approximately $4.477 million for the year ended December 31, 2024, compared to a net loss of $3.403 million for 2023, raising concerns about its ability to continue as a going concern[130]. - Cash used in operations was approximately $1.44 million in 2024, down from $3.599 million in 2023, highlighting a potential improvement in operational efficiency[130]. - The company has an accumulated deficit of $54.3 million as of December 31, 2024, which poses a significant financial challenge[130]. - Research and development expenses for the years ended December 31, 2024 and 2023, were approximately $291,000 and $492,000, respectively, indicating a decrease in investment[117]. Strategic Partnerships and Collaborations - The company secured significant agreements and new partnerships to enhance the distribution of the SteraMist brand globally[201]. - In 2024, the company contracted with six different partners across regions including Malaysia, India, Canada, Korea, and the United Kingdom[202]. - The partnerships span focused industries such as pharmaceuticals, vivarium, emergency services, and general disinfection and cleaning[202]. - A strategic partnership with EMAQ was formed in Q2 2024, with EMAQ investing over $1,000,000 in SteraMist iHP equipment to enhance market presence in the western United States[204]. - The partnership with PBSC and other OEMs aims to enhance turnkey solutions and create additional revenue streams for the company[211]. Challenges and Risks - The company does not have long-term customer contracts, making future revenue uncertain and exposing it to competitive price pressures[127]. - The BIT technology for Hospital-Healthcare disinfection has not yet achieved broad market acceptance, which could delay sales growth[129]. - The company relies on third-party manufacturers for its SteraMist® products, increasing risks related to supply chain disruptions and compliance with regulatory requirements[139]. - The company faces various international business risks, including currency fluctuations and compliance with export control laws, which could adversely affect its operations[131]. - The decontamination and environmental infectious disease control industry is highly competitive, with significant competitors having greater resources and established products[151]. - The company faces risks related to product liability claims, which could adversely affect its financial condition and operations[161]. Operational Developments - The company is committed to expanding its marketing and educational campaigns to drive adoption of the SteraMist iHP product line across various industries[58]. - The company is focused on ongoing projects and validations for its Custom Engineered System (CES), which involves longer lead times for installation and commissioning[90]. - The company is actively pursuing options to raise capital, including issuing convertible notes, but there is no assurance of success in these efforts[130]. - The company is in the process of developing remediation plans to address identified material weaknesses in internal controls over financial reporting[169]. - The company has hired additional sales personnel, but their productivity levels are yet to be realized, which may impact revenue growth[126]. Future Outlook - In 2024, the company anticipates a positive material impact from installations of CES permanent decontamination rooms, expecting increased utilization of BIT Solution to contribute to overall growth[91]. - The company plans to continue investing in research and development, focusing on new sanitizing robotic devices and backpack units[154]. - The company aims to be a global leader in disinfection and decontamination products, continuing to expand research and development and forming strategic business alliances[114]. - The company is expanding operations internationally, facing challenges in enforcing intellectual property rights in foreign jurisdictions[149]. - The company is committed to onboarding additional service providers to support the SteraMist iHP disinfection technology across various industries[205].

Company Overview - TOMI Environmental Solutions, Inc. specializes in disinfection and decontamination solutions, utilizing its proprietary Binary Ionization Technology (BIT) platform [4] - The BIT solution employs a low percentage of hydrogen peroxide as its active ingredient, enhanced by patented ionized Hydrogen Peroxide (iHP) technology [4] - TOMI's products cater to a wide range of sectors, including hospitals, biosafety labs, pharmaceutical facilities, schools, and commercial buildings [4] Upcoming Financial Reporting - TOMI will report its fourth-quarter results for the period ending December 31, 2024, on April 14, 2025, after market close [1] - A conference call to discuss the results will take place at 4:30 p.m. ET on the same day [1] Participation Details - Participants can join the conference call by dialing (888) 506-0062 or (973) 528-0011 for international callers, using access code 818389 [2] - A replay of the teleconference will be available until April 28, 2025, with specific dialing instructions provided [3]

Core Insights - TOMI Environmental Solutions, Inc. has announced an OEM partnership with Pharma Biotech System Components LLC, enhancing its SteraMist Integrated System (SIS) product line [1][3] - The collaboration aims to leverage PBSC's expertise in high-containment solutions to expand the adoption of SteraMist in critical industries [3][4] - TOMI's SIS will now include pass-through hatches and chambers integrated with ionized Hydrogen Peroxide (iHP) technology for optimized decontamination cycles [1][4] Company Overview - TOMI Environmental Solutions, Inc. is a global leader in disinfection and decontamination solutions, utilizing its proprietary Binary Ionization Technology (BIT) platform [4] - The company’s products are designed for a wide range of applications, including hospitals, pharmaceutical facilities, and commercial buildings [4] - BIT technology employs a low percentage of hydrogen peroxide as its active ingredient, providing superior disinfection capabilities [4] Industry Context - PBSC is recognized as a leading manufacturer of cleanroom and material decontamination products, catering to the pharmaceutical and medical research sectors [2] - The partnership is expected to meet the increasing demand for integrated disinfection solutions in high-containment environments [3][4] - Current projects are underway, indicating strong market demand for TOMI's innovative SIS system [3]

Core Insights - TOMI Environmental Solutions, Inc. has secured a significant contract valued at approximately $450,000 to install a SteraMist iHP Custom Engineered System at a leading university in Rhode Island, highlighting its competitive advantage over hydrogen peroxide competitors [1][2] - The demand for enhanced decontamination solutions among academic institutions is increasing, as TOMI's SteraMist technology demonstrates superior performance compared to traditional systems [2][3] - TOMI's SteraMist iHP technology is expected to remain a preferred choice for disinfection in Boston's life science industry, with additional sales secured at a private university in Massachusetts [3] Company Overview - TOMI Environmental Solutions specializes in disinfection and decontamination solutions, utilizing its proprietary Binary Ionization Technology (BIT) platform, which employs a low percentage of hydrogen peroxide as the active ingredient [4] - The company’s products are designed for a wide range of applications, including hospitals, biosafety labs, pharmaceutical facilities, and educational institutions [4]

Core Insights - TOMI Environmental Solutions, Inc. has successfully implemented its SteraMist technology at Algafeed, addressing contamination issues in microalgae production for aquaculture [1][2] - Algafeed faced significant Protozoan ciliate contamination, which was effectively reduced through the use of SteraMist, allowing for improved production volumes [2][4] - The partnership between TOMI and Algafeed highlights the versatility of SteraMist technology in various industries, particularly in aquaculture [4] Company Overview - TOMI Environmental Solutions, Inc. specializes in disinfection and decontamination solutions, utilizing its Binary Ionization Technology® (BIT™) platform, which employs a low percentage of hydrogen peroxide as the active ingredient [5] - The company’s products are designed for a wide range of applications, including hospitals, pharmaceutical facilities, schools, and food processing facilities [5] Industry Context - Algae serves as a primary food source in aquaculture, and Algafeed's innovative technology allows for high-density microalgae cultivation, providing a competitive edge in the industry [3] - The successful application of SteraMist technology in the aquaculture sector demonstrates the growing importance of effective disinfection solutions in maintaining production efficiency [2][4]

Core Insights - TOMI Environmental Solutions, Inc. has successfully deployed its SteraMist iHP technology at NASA Johnson Space Center, marking its entry into the aerospace sector [1][2] - The technology is being utilized in a biosafety cabinet for handling samples from the Mars Perseverance Rover mission, demonstrating its application in space exploration [2][3] - This deployment is part of TOMI's strategic SteraMistX campaign, which aims to enhance biosecurity standards in aerospace and military fields [4] Company Overview - TOMI Environmental Solutions, Inc. is a global leader in disinfection and decontamination solutions, utilizing technology developed through DARPA [1][5] - The company's primary product, the Binary Ionization Technology (BIT) platform, employs a low percentage of hydrogen peroxide as its active ingredient, providing superior disinfection capabilities [5] - TOMI's products are designed for a wide range of environments, including hospitals, biosafety labs, pharmaceutical facilities, and more [5]

Group 1 - TOMI Environmental Solutions, Inc. will participate in the Q1 Investor Summit Event on March 11, 2025, with Dr. Halden Shane as the representative [1][2] - The conference will include one-on-one meetings for investors, allowing for direct engagement with the company [2] - TOMI specializes in disinfection and decontamination through its Binary Ionization Technology (BIT) platform, primarily marketed under the SteraMist brand [3] Group 2 - The BIT platform utilizes a low percentage of hydrogen peroxide as its active ingredient, employing patented ionized Hydrogen Peroxide (iHP) technology for superior disinfection [3] - TOMI's products are applicable in various environments, including hospitals, biosafety labs, pharmaceutical facilities, and commercial buildings [3]

Core Insights - TOMI Environmental Solutions, Inc. has achieved compliance and recognition from Avetta, highlighting its commitment to health, safety, and environmental excellence [1][2] - The addition of Avetta complements TOMI's existing memberships with Highwire and ISNetworld, reinforcing its dedication to high safety and compliance standards [2] - The COO of TOMI emphasized that this accomplishment enhances credibility with clients and opens new avenues for engagement with industry leaders [3] Company Overview - TOMI Environmental Solutions, Inc. specializes in disinfection and decontamination, utilizing its proprietary Binary Ionization Technology (BIT) platform, which employs low percentage hydrogen peroxide as the active ingredient [4] - The company's products are designed for a wide range of applications, including hospitals, pharmaceutical facilities, schools, and public safety departments [4]

Company Overview - TOMI Environmental Solutions, Inc. specializes in disinfection and decontamination solutions, utilizing its proprietary Binary Ionization Technology (BIT) platform [5] - The company’s SteraMist technology is being deployed in California to assist in recovery efforts following recent wildfires [1][2] Industry Impact - SteraMist is being used by service providers to decontaminate structures affected by smoke and hazardous particulates, addressing issues such as air quality and toxic substances [2][3] - The deployment of SteraMist is part of the EPA's broader recovery plan, which includes hazard removal and fire restoration efforts [2] Partnerships and Collaborations - TOMI collaborates with service providers like South Coast Water Damage and Vista Pacific Construction to enhance disaster recovery efforts [4] - The company is also working with federal and state-licensed service providers, insurers, and regulatory agencies to streamline remediation processes [4] Commitment to Innovation - TOMI is dedicated to leveraging its decontamination solutions to support communities affected by natural disasters while expanding its market presence in restoration and environmental health [4]